Research is highlighting trends in the drug target landscape for autoimmune diseases, with a focus on emerging areas such as the role of microbiota and adaptive immunity. The development of new treatments, including CAR T cells and targeted therapies, is also being explored. The growth of the immunology market and advancements in drug discovery and repurposing are expected to shape the future of autoimmune disease treatment.